Related Experiment Video
Updated: Jan 16, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.3K
Practice Gap in Addressing Secondary Tricuspid Regurgitation During Systemic Valve Surgery for Rheumatic Heart
Siddharth V Som1, Ankus S Kotwal1, Amit Rastogi2
1Cardiovascular Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, IND.
Cureus
|October 6, 2025
Summary
This study found that tricuspid regurgitation (TR) progression was similar in patients with severe TR and pulmonary hypertension, whether or not they had tricuspid valve repair (TVr). Further investigation is needed for this patient group.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Practice Guidelines
Background:
- Tricuspid regurgitation (TR) is a common complication in patients undergoing left-sided valve surgery.
- Addressing TR in these patients presents a practice gap, particularly concerning the need for tricuspid valve repair (TVr).
Purpose of the Study:
- To analyze the practice gap in managing tricuspid regurgitation (TR) in patients undergoing left-sided valve surgery.
- To evaluate the outcomes of TVr in patients with moderate to severe TR and a dilated tricuspid valve annulus.
Main Methods:
- Retrospective cohort study of 1,129 patients undergoing left-sided valve operations for rheumatic heart disease between 2015-2018.
- Patients were divided into four groups based on TR severity and pulmonary arterial hypertension (PAH) status.
- Primary endpoint was the appearance of severe TR at follow-up; TVr was performed in 68 patients with moderate to severe TR and a dilated annulus.
Main Results:
- The primary endpoint (severe TR) was observed in 6.3% (mild TR), 21.1% (severe TR with PAH), 49.5% (severe TR, non-severe PAH), and 23.5% (moderate-severe TR with dilated annulus).
- Severe TR developed more frequently in patients with moderate TR preoperatively (p=0.04).
- There was a departure from AHA/ACC guidelines in 66.6% of cases involving severe TR; severe TR emergence was similar in Group 2 (no TVr) and Group 4 (TVr).
Conclusions:
- The development of severe TR during follow-up was similar for patients with preoperative severe TR and severe pulmonary hypertension, regardless of TVr.
- The need for TVr in patients with severe TR and severe pulmonary hypertension requires further investigation.
Keywords:
long term followupoutcome analysisrheumatic valvular heart diseasesecondary tricuspid regurgitationvalve replacement surgeryMore Related Videos
Related Concept Videos
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
482
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
482
01:20Mitral Regurgitation I: Introduction
415
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
415
01:21Rheumatic Heart Disease III: Medical Management
285
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
285
01:25Mitral Regurgitation III: Medical Management
279
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
279
01:22Mitral Valve Prolapse II: Assessment and Management
418
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
418
01:23Rheumatic Heart Disease I: Introduction
433
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
433